Search bioRxiv⌕ Search

Biology subjects

Luo, Y.

Publications and source records attributed to Luo, Y..

At least 73 records · Page 4Linked to original sources

Evolutionary profile enhancement improves protein function annotation for remote homologs

Accurate annotation of protein function is essential for understanding biological processes, yet this remains challenging for proteins lacking characterized homologs or belonging to underrepresented functional classes. Although machine learning approaches have become the gold standard for automated function prediction, they often perform poorly on out-of-distribution samples with low sequence identity to training proteins with known annotations. We propose EPERep, an evolutionary input enhancement strategy that leverages the vast space of unannotated protein sequences to improve the prediction of the functions of underrepresented proteins. Our key insight is that, even if a query protein has insufficient similarity to annotated proteins for direct annotation transfer, a wider range of similar unannotated sequences can be identified to facilitate better representation learning. Inspired by profile-based sequence search methods, EPERep incorporates homologous sequences as contextual input to refine the representations of individual proteins from pre-trained protein language models, effectively constructing a pLM-based profile for each query protein. Across four major annotation benchmarks on EC numbers, structural domains, Pfam families, and Gene Ontology predictions, EPERep consistently outperforms strong ML and sequence-alignment baselines. Gains are most pronounced for proteins from rare functional classes, with few or no labeled homologs, and for sequences exhibiting remote homology to the training distribution. These results demonstrate that evolutionary input enhancement provides a principled and scalable strategy for improving protein function prediction, particularly in long-tail and low-identity regimes.

bioinformatics↗

Shared network between social exclusion and physiological needs

We investigated the neural substrates underlying the brain network shared by social exclusion and physiological needs, both viewed as instances of deprivation. Using activation likelihood estimation (ALE) meta-analyses, we examined brain activation patterns from studies where participants perceived food/water while hungry/thirsty and social interactions while experiencing exclusion. This analysis revealed overlapping activation in the mid-posterior insula, caudate head and ventral anterior cingulate cortex (ACC), as regions consistently engaged when perceiving relevant stimuli across both physiological and social deprivation. Furthermore, we found high spatial correlation between this shared network and the distribution of dopamine receptors, and we identified a significant positive correlation with the 5HT4 among serotonin receptors. Our findings suggest that perceiving deprivation-related stimuli activates brain regions and neurotransmitters involved in aversive affect and goal-directed behavior. These results highlight a neural bridge linking basic physiological drives with complex social needs, offering new insights into the neurobiological architecture of human affective states--while representing just one part of a much larger puzzle.

neuroscience↗

The structure and catalytic mechanism of new cellular and viral HDV ribozymes

We have determined the molecular structure and investigated the catalytic mechanism of two new ribozymes of the Hepatitis delta virus family, found in the nematode Caenorhabditis briggsae and virus Ackermannviridae. Crystal structures of both conform to the double-pseudoknot architecture adopted by the viral HDV ribozyme. The C. briggsae ribozyme has been determined both pre- and post-cleavage. In the former both nucleotides flanking the scissile phosphate are observed, along with a metal ion, and cytosine 75 N3 bound to the O5 leaving group. The pH dependence of cleavage rate reveals a pKa of 6.6 and together with the inactivity of a C75U mutant provides evidence for its role as general acid. In contrast to other nucleolytic ribozymes that use catalytic metal ions, reaction rate does not depend on the pKa of the divalent metal ion. Limited adjustment of structure of the active center is consistent with direct bonding of the metal ion to the O2 and non-bridging O, suggesting that the ion acts as a Lewis acid to activate nucleophilic attack. This mechanism appears to be general for the HDV ribozyme class, and distinguishes it from the majority of nucleolytic ribozymes that use general base catalysis.

biochemistry↗

Vagus Nerve Stimulation Ameliorates Epilepsy via a Gut Microbiota-Butyrate-Vagus Nerve-Brain Axis

Vagus nerve stimulation (VNS) is an established therapy for drug-resistant epilepsy, yet its mechanism remains partially understood. Here, through an integrated clinical-translational approach, we demonstrate that VNS modulates the gut microbiome and alter the level of butyrate to reduce seizure susceptibility via vagus nerve-dependent signaling. In a longitudinal cohort of epilepsy patients, VNS enriched short-chain fatty acid-producing bacteria, including Akkermansia muciniphila, Prevotella, Alistipes, and Odoribacter. Among clinical responders, fecal butyrate levels decreased concomitantly with an increase in plasma butyrate concentrations. Fecal microbiota transplantation from post-VNS patients into mice reduced seizure severity and improved gut barrier integrity. In a murine model of epilepsy, VNS similarly increased the abundance of Akkermansia and plasma butyrate concentrations, decreased fecal butyrate levels, and abolished its antiseizure effects upon vagotomy. Either colonization with Akkermansia muciniphila or exogenous butyrate supplementation was sufficient to reduce seizures and anxiety-like behavior, effects that also required intact vagal signaling. Our findings define a microbiota-butyrate-vagal pathway essential for the therapeutic effects of VNS, highlighting the gut-brain axis as a target for epilepsy treatment. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/707138v1_ufig1.gif" ALT="Figure 1"> View larger version (75K): org.highwire.dtl.DTLVardef@8243e6org.highwire.dtl.DTLVardef@37f0e6org.highwire.dtl.DTLVardef@a8b321org.highwire.dtl.DTLVardef@1887342_HPS_FORMAT_FIGEXP M_FIG C_FIG HIGHLIGHTSO_LIVagus nerve stimulation (VNS) remodels the gut microbiota and alter the level of butyrate. C_LIO_LIVNS enriches short-chain fatty acids-producing bacteria, specifically Akkermansia muciniphila, in both humans and mice. C_LIO_LITransplantation of VNS-conditioned microbiota confers seizure protection and restores gut barrier integrity. C_LIO_LIAkkermansia muciniphila or exogenous butyrate is sufficient to reduce seizures via a vagus nerve-dependent pathway. C_LI

neuroscience↗

NRF2 pathway activation and SPP1⁺TREM2⁺ macrophages drive chemoradiotherapy resistance in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is among the most aggressive cancers, with low rates of durable response to chemoradiotherapy and limited therapeutic options for relapsed disease. To uncover mechanisms of treatment resistance and relapse, we performed comprehensive multi-omics profiling of >100 pre-treatment and post-relapse ESCC tumors from a prospective clinical trial (NCT04694391), integrating whole-exome/genome sequencing, bulk RNA-sequencing, single-cell RNA sequencing, and spatial transcriptomics. We identify somatic alterations in NFE2L2/KEAP1 in nearly 40% of relapsed patients, which are associated with upregulation of NRF2 signaling targets in resistant tumors and cell line models. At single-cell and spatial resolution, relapsed tumors are enriched for NRF2-activated epithelial cells that physically co-localize with immunosuppressive SPP1TREM2 macrophages. This co-localization suggests a synergistic interaction between NRF2-driven tumor programs and macrophage-mediated immune suppression that promotes relapse after chemoradiotherapy. Our findings nominate NFE2L2/KEAP1 mutations as predictive biomarkers for patient stratification and highlight therapeutic targeting of NRF2 signaling and SPP1TREM2 macrophages as rational strategies to overcome resistance in ESCC.

cancer biology↗

SMECT: a framework for benchmarking post-GWAS methods for spatial mapping of cells associated with human complex traits

Spatially resolving the cellular basis of complex human traits is essential for elucidating disease mechanisms, yet the comparative performance of computational methods for this task has not been systematically evaluated. Here, we present SMECT (Spatial Mapping Evaluation of Complex Traits), the first comprehensive framework for systematically evaluating methods that integrate genetic data with spatial transcriptomics. SMECT combines a biologically realistic simulation engine, a curated resource of 21 diverse real-world datasets, and a multi-faceted assessment toolkit. Using this framework, we benchmarked three state-of-the-art methods--DESE, S-LDSC, and scDRS--across 19 complex traits. Our analysis reveals a fundamental trade-off between detection sensitivity and biological specificity. We demonstrate that while S-LDSC identifies extensive spatial signals, it suffers from inflated non-specific significant associations. Conversely, scDRS is highly specific but conservative, performing well only in tissues with strong biological signals while missing subtle associations in sparser datasets. DESE overcomes these limitations, consistently achieving high power and robust specificity across both simulated and real-world scenarios. SMECT provides critical guidelines for method selection and serves as a foundational resource for developing robust spatial analyses of human complex traits. The framework is publicly available at https://github.com/pmglab/smect.

bioinformatics↗

Enhancing Pan-cancer Spatial Transcriptomics atSingle-cell Resolution with stPainter

Subcellular spatial transcriptomics technologies offer unprecedented views of tissue architecture but are fundamentally constrained by sparse gene panels and limited detection sensitivity. Current computational enhancement strategies typically rely on tissue-matched single-cell RNA sequencing (scRNA-seq) references and necessitate computationally intensive retraining for each dataset, impeding their scalability and clinical applicability. Here, we present STPAINTER, a conditional generative model that leverages a massive pretraining pan-cancer scRNA-seq atlas to universally enhance spatial transcriptomics data. Built upon a latent diffusion architecture with stochastic differential equation-guided generation, STPAINTER learns a universal manifold of cellular states to reconstruct genome-wide expression profiles from sparse spatial measurements. Uniquely, our pretraining paradigm enables zero-shot generalization and empowers downstream tasks by providing imputed transcriptomes and informative latent variables to enhance resolution at both the gene and cluster levels. Applied STPAINTER upon 6 spatial transcriptomics datasets of different cancer types, we demonstrate that our model empowers high-fidelity downstream analyses, including fine-grained subpopulation clustering and pathway enrichment. Furthermore, cross-validation with spatially resolved proteomics (CODEX) confirms the biological veracity of the imputed cellular landscapes. STPAINTER provides a robust, scalable framework for decoding complex tumor microenvironments without the need for auxiliary sequencing data.

bioinformatics↗

Chronic Unpredictable Stress Drives Non-pathological, Adaptive Metabolic Hormone Reprogramming with Reduced Insulin Resistance Linked to Depressive-like Behaviors

Major Depressive Disorder (MDD) is increasingly conceptualized as a neuroimmune-metabolic-oxidative stress (NIMETOX) condition, partly driven by environmental stressors. While new antidepressant strategies have emerged to target NIMETOX pathways, the mechanism by which chronic stress reshapes metabolic regulation-particularly in the absence of clinically overt metabolic disease-remain poorly understood. Using a 6-week chronic unpredictable mild stress (CUMS) paradigm in metabolically healthy male and female mice, we evaluated depressive-like behaviors alongside circulating glucose and metabolic hormones, including insulin, resistin, Glucose-dependent Insulinotropic Polypeptide (GIP), Glucagon-like Peptide-1 (GLP-1), glucagon, ghrelin, leptin, and Plasminogen Activator Inhibitor-1 (PAI-1). We further assessed whether simvastatin, curcumin, S-adenosyl methionine (SAMe), or pyrrolidine dithiocarbamate (PDTC), an NF-{kappa}B inhibitor, normalize CUMS-induced metabolic and behavioral alterations, using fluoxetine as a reference antidepressant. CUMS induced a hypoinsulinemic state accompanied by enhanced basal insulin sensitivity and reduced insulin resistance, while central appetite regulation and adipose inflammatory profiles remained preserved. Indices of lower insulin resistance were strongly associated with sucrose preference and immobility time. Glucagon and PAI-1 showed positive associations with novel object recognition performance, whereas GIP and leptin were inversely related to open-field activity. Glucose levels correlated positively with rearing behavior. Despite significant improvements in depressive-like behaviors, none of the pharmacological interventions normalized the stress-induced metabolic hormone profile. Marked sex differences were observed, with females displaying a catabolic, immune-ready phenotype and males showing a relative anabolic bias. These findings indicate that CUMS induces a non-pathological, adaptive metabolic hormone reprogramming rather than metabolic dysfunction, supporting the interpretation of stress-related metabolic changes as resilient adaptations within the NIMETOX framework.

neuroscience↗

Detection of Somatic Point Mutations Directly from Spatial Transcriptomics Enables in vivo Spatiotemporal Lineage Tracing

Spatial transcriptomics reveals tissue organization but lacks in vivo lineage-tracing methods applicable to humans. We introduce SpaceTracer, a computational framework that accurately detects somatic single-nucleotide variants (SNVs) directly from spatial transcriptomics data. By leveraging naturally occurring somatic SNVs, SpaceTracer reconstructs cellular phylogenies within native tissue architecture, enabling the mapping of lineage spread, migration, lineage-coupled expression changes and lineage-aware local interactions. Applied to human cutaneous squamous cell carcinoma, it traced tumor initiation and progressions, uncovered widespread pre-invasive migration of dedifferentiated epithelial cells and characterized mutant B cells migrating from tertiary lymphoid structures (TLS) into the tumor boundary. The framework also reconstructed developmental lineages across multiple tissues and identified tissue-resident mutant immune cells. SpaceTracer thus provides a perturbation-free platform for high-resolution spatiotemporal lineage tracing, offering a transformative tool for elucidating complex biological systems--especially tumor-immune ecosystems--with direct implications for advancing cancer immunotherapy.

bioinformatics↗

Unravelling genome-wide mosaic microsatellite mutations at single-cell resolution

Short tandem repeats (STRs), or microsatellites, are highly mutable genomic elements that modulate gene regulations and are implicated in a range of human diseases. However, detecting mosaic STR mutations at single-cell resolution remains challenging due to both technical and biological complexities. To address this, we developed BayesMonSTR, a robust algorithm that enables accurate detection of mosaic STR mutations. Using this tool in single-cell analysis of human tissues, we reveal an accumulation of longer mosaic STR insertions and deletions (indels) in aging mitotic and post-mitotic cells. Strikingly, prefrontal cortex (PFC) neurons accumulate a higher burden of STR mutations than B cells or lung epithelium, with aged neurons exhibiting a particularly pronounced increase in longer STR deletions. These mutations are enriched at transcription start sites (TSSs) and active enhancers of highly expressed genes. Our work establishes a foundation for genome-wide, hypothesis-free discovery of disease-associated mosaic STR mutations and reveals a previously unexplored landscape of mosaic STR variation in development and aging.

bioinformatics↗

Deconvolving mutation effects on protein stability and function with disentangled protein language models

Understanding how evolutionary constraints shape protein sequences is fundamental to deciphering the molecular mechanisms underlying protein stability and function, which has broad implications in protein engineering and therapeutics development. Recent advances in protein language models (pLMs) have enabled accurate prediction of mutation effects through evolutionary information, effectively capturing the selective pressure that governs protein sequence variation. A critical challenge, however, remains in disentangling the intertwined mutation effects on protein stability and function, as evolutionary signals conflate both stability-driven and function-driven pressures, obscuring the mechanistic basis of mutation effects and limiting their utility for rational protein engineering. In this work, we introduce DETANGO, a novel deep learning framework that explicitly deconvolves the mutation effects on protein functions by removing components attributable to stability perturbations from the pLM-predicted mutation effects. Guided by computational or experimental stability measurements, DETANGO estimates a functional plausibility score for each single-point mutation that is the component of the mutation effect not accounted for by changes in stability. Single-point mutations with low functional plausibility are predicted to be stable-but-inactive (SBI) variants, whose compromised activities are caused by direct perturbations on functional mechanisms rather than structural stability. Residues enriched for such variants are inferred to be functionally critical, as indicated by the strong evolutionary pressures to maintain protein function. Through extensive benchmarking experiments, we show that DETANGO accurately identifies SBI variants and pinpoints functionally important residues across contexts, including ligand binding, catalysis, and allostery. Moreover, extending DETANGO from individual proteins to homologous protein families reveals shared and distinctive functional patterns across protein families. Collectively, these results establish DETANGO as a biologically grounded framework for disentangling evolutionary constraints on protein stability and function, advancing mechanistic understanding of protein function, and informing rational protein engineering.

bioinformatics↗

Selective Disruption of Plasmodium falciparum mitochondrial DNA via G-Quadruplex-Binding Ligand RHPS4 Provides a Novel Antimalarial Strategy

Malaria caused by Plasmodium falciparum remains a major health threat, killing over 600,000 people annually. The spread of resistance to all major antimalarials, including artemisinins, highlights the urgent need for new drugs with distinct mechanisms of action. Here we show that the G-quadruplex ligand RHPS4, an acridine derivative, displays strong antiplasmodial activity against both drug-sensitive and -resistant P. falciparum strains and clinical isolates. RHPS4 primarily targets the trophozoite stage and induces major mitochondrial alterations, including reduction of mitochondrial DNA (mtDNA) and transcriptional dysfunctions. Bioinformatic analyses identified at least eight putative G4-forming sequences within the parasites mtDNA. Biophysical studies confirmed G4 folding of at least one sequence and its interaction with RHPS4. These findings indicate that RHPS4 disrupts P. falciparum mitochondrial metabolism through G4 stabilization, leading to parasite death, and establish mtDNA G4 structures as novel therapeutic targets for antimalarial development.

microbiology↗

STUltra: scalable and accurate integration for subcellular-level spatial omics data

High-resolution spatial transcriptomics (ST) is generating massive datasets involving multiple tissue sections, continuous developmental stages, or various disease conditions. Yet, their scale, biological heterogeneity, and substantial batch effects hinder data integration for further analysis, particularly the temporal interpretation of disease-associated spatial domains within tissue organization landscapes. Here, we present STUltra, a scalable hypergraph framework that integrates multi-sample ST data for precise domain detection and genome-wide association study (GWAS)-based disease trait mapping. From ST datasets, STUltra first constructs interval-sampled integrative hypergraphs, in which hyperedges capture tissue neighborhoods within the slices as well as shared biological contexts across the slices. It then combines a robust graph autoencoder with contrastive learning to learn batch-corrected, spatially informed embeddings for identifying spatial domains across the tissue sections. These embeddings are then coupled with GWAS statistics to map trait-associated signals onto the integrated tissue sub-structure landscapes spanning different sections, developmental stages, and disease conditions. STUltra substantially outperforms competing methods, especially being much faster, on diverse integration benchmarks, enabling efficient processing of datasets containing millions of spots. As a case study on a mouse embryo dataset, STUltra recovered continuous developmental programs and mapped congenital heart disease signals beyond cardiac regions to broader programs including vascular and mesenchymal domains. On a mouse Alzheimer's disease dataset, STUltra prioritized localized AD-associated genetic signals to microglia and a disease-expanded C1QA/HEXB-high astrocyte state. Together, STUltra provides a scalable framework to bridge the gap between spatiotemporal tissue structures and complex disease traits, facilitating discoveries from previously unrecognized molecular and cellular architectures across diverse contexts.

bioinformatics↗

Use-dependent learning biases the initial state but not the learning dynamics of implicit adaptation

Motor adaptation arises from multiple learning mechanisms, including use-dependent learning (UDL) driven by repetition and implicit error-based learning (EBL) driven by motor prediction errors. Although both mechanisms contribute implicitly to shaping movement execution, whether these two mechanisms interact remains unclear. The present study used an error-clamp (EC) task to isolate implicit EBL and directly examined whether UDL affects subsequent implicit adaptation. Participants first performed extensive single-target repetitive reaches to induce use-dependent biases and then immediately transitioned to an EC task. We manipulated whether the UDL bias was aligned with, opposed to, or neutral toward the to-be-adapted direction in three separate groups of participants. Results demonstrate that UDL robustly shifted the initial state of adaptation, but did not alter the learning dynamics: all groups showed comparable trial-by-trial adaptation and converged to similar asymptotic levels despite their different initial states. These findings support an independent rather than an interactive relationship between UDL and implicit EBL, highlighting that execution-level motor learning components are additive.

animal behavior and cognition↗

Cryo-EM structures of anti Z-DNA antibodies in complex with antigen reveal distinct recognition modes of a left-handed geometry

Double-stranded nucleic acids can undergo transitions from canonical B/A-forms to alternate left-handed Z-DNA/Z-RNA (Z-NAs). Z-NAs are implicated in processes such as neuroinflammation in Alzheimers disease, Lupus Erythematosus, microbial biofilms, and type I interferon-mediated human pathologies. Since endogenous Z-NA sensors like the Z domain can induce B-to-Z transitions, monoclonal antibodies (mAbs) Z-D11 and Z22 have been regarded as conformation-specific tools to confirm Z-NA in situ, although high-resolution structural information is missing. Here, we employed single-particle cryo-electron microscopy to solve structures of Z-D11 and Z22 bound to synthetic d(CG)6 12mer Z-DNA duplex. Both mAbs form filamentous trimers around the Z-DNA axis, further stabilized by Fab-Fab interactions. The mAbs achieve specificity through extensive contacts to both Z-form backbone strands and the exposed guanine/cytosine bases in the major groove. This mode of recognition is dictated by shape complementarity rather than sequence specificity, sensing the alternating syn/anti backbone torsions and the phosphate zig-zag geometry unique to Z-DNA. Our data also suggest that these mAbs are not inducing B-to-Z transitions under normal physiological conditions. Finally, comparison to other double-stranded NA-binding mAbs defines a similar structural logic adapted to different helical geometry recognition patterns, thus providing a framework for engineering highly specific nucleic acid probes.

biochemistry↗

PPARgene 2.0: leveraging large language models and multi-omics data for enhanced identification and prediction of PPAR target genes

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of the nuclear receptor superfamily. Upon ligand binding, PPARs activate target gene transcription and regulate a variety of important physiological processes such as lipid metabolism, inflammation, wound healing and immune responses. PPARgene is a database that integrates literature-curated and computationally predicted PPAR target genes. It provides gene-level annotations including tissue specificity, species, and supporting PubMed IDs. Computational predictions are generated using a machine learning method that combines PPRE motif analysis with microarray expression data. Here, we introduce PPARgene 2.0, a 10-year update to the original PPARgene database. This update adds 35 newly reported PPAR target genes, 20 PPAR{beta}/{delta} target genes, and 72 PPAR{gamma} target genes, bringing the total number of curated target genes in the database to 337. To retrieve newly reported PPAR target genes from the literature, we used two language models to screen publications after 2016. Candidate papers were then manually reviewed, and verified target genes were added to the updated database. This update also improved the predictive method by expanding the volume of high-throughput gene expression data and incorporating PPAR-related ChIP-seq datasets alongside in silico PPRE analysis. Fivefold cross-validation demonstrated that the new predictive method outperforms the original one. The updated prediction tool is available as part of the PPARgene 2.0 platform. The database is openly accessible at https://www.ppargene.org.

bioinformatics↗

Organoid Pharmacotyping of Pancreatic Cancer Enables Functional Precision Oncology and Drug Repurposing

PurposePancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies, with limited benefit from current cytotoxic regimens and poor predictive value of genomics alone. Patient-derived organoids (PDOs) represent a promising platform for functional precision oncology, yet systematic pharmacotyping of genomically annotated PDAC PDOs remains sparse. Experimental DesignWe established a clinically annotated panel of ten treatment-naive PDAC PDOs spanning well-, moderately-, and poorly differentiated tumors. PDOs were evaluated for morphologic and genomic fidelity and screened against 1,813 clinically relevant small molecules in a high-throughput 384-well format. Drug sensitivities were quantified at the compound and drug-family levels and integrated with histologic grade, pathway-level mutational profiles, and available clinical treatment information. ResultsPDOs preserved hallmark tumor features, including glandular organization and subclonal mutational architecture. Pharmacotyping revealed both shared and subtype-specific vulnerabilities. Classical (well/moderately differentiated) PDOs showed enriched mutations in DNA repair, mitotic spindle, and chromatin-regulatory pathways and were preferentially sensitive to topoisomerase inhibitors, microtubule poisons, and HDAC inhibitors. In contrast, basal (poorly differentiated) PDOs displayed coordinated defects in mitochondrial function, vesicle trafficking, and ubiquitin-mediated proteostasis, at the pathway level, that conferred a previously unrecognized vulnerability to cardiac glycosides. Sensitivities to standard PDAC agents were heterogeneous across models, underscoring the limited predictive value of genotype alone and the need for functional drug testing. ConclusionsThis integrated genomic and pharmacologic analysis demonstrates that PDO pharmacotyping identifies biologically grounded, actionable vulnerabilities in PDAC, including novel therapeutic opportunities in basal, chemo-resistant tumors. These findings support PDO-guided functional profiling as a clinically relevant platform for refining drug selection and expanding treatment options for patients with PDAC. SignificancePDAC is dominated by chemoresistance and lacks reliable genomic predictors of therapy response. By integrating high-throughput drug screening with mutation-informed pathway analysis in patient-derived organoids, we identify differentiation-linked therapeutic liabilities, including a previously unrecognized vulnerability to cardiac glycosides in basal PDAC. These results highlight PDO pharmacotyping as a powerful functional complement to genomics for guiding treatment selection in pancreatic cancer.

cancer biology↗

Interrogating the Regulatory Function of HAQERs during Human Cortical Development

BackgroundSequence divergence within gene regulatory elements has been proposed to play an important role in the evolution of human-specific traits, including cortical expansion. However, the mutational processes that efficiently modify gene regulatory elements and the target genes upon which they act are poorly understood. We investigated the regulatory function and origins of the fastest evolved regions in the human genome, termed Human Ancestor Quickly Evolved Regions (HAQERs), in their native genomic context during human cerebral cortex development. ResultsWe identified 50 HAQERs with accessible chromatin in developing human cortex, largely arising from previously unconstrained ancestral sequences. To test the necessity of these HAQERs for gene regulation, we established an all-in-one CRISPRi lentiviral vector and linked 26 HAQERs to nearby target genes across cell types and Wnt pathway activation contexts. Rapid gains of CpGs distinguished HAQERs active during cortical development and displaying human-specific epigenomic marks. As a high density of CpG sites can drive formation of permissive chromatin, we identified 107 HAQERs with at least 17 human-specific CpG gains per kb, termed HAQER CpG Beacons. These HAQERs emerged via contributions from GC-biased gene conversion (gBGC) with evidence for selection preferentially fixing CpG sites. Notably, the CHL1 and DPP10 loci, both implicated in human neurological disorders, each harbored two gene-linked HAQER CpG Beacons. ConclusionsOur findings reveal HAQER target genes and support a model where gBGC and natural selection jointly drive regulatory-altering CpG variants to fixation, forging regulatory innovations in the human cortex.

evolutionary biology↗